Journal article
Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691.
Authors
Koska J; Gerstein HC; Beisswenger PJ; Reaven PD
Journal
Diabetes Care, Vol. 45, No. 6, pp. e111–e112
Publisher
American Diabetes Association
Publication Date
June 2, 2022
DOI
10.2337/dci22-0013
ISSN
0149-5992